We focus on understanding the role of hormones, reproductive exposures, and gender on inflammation, repair, and patient experiences in MS.

MS affects three times more women than men. This raises a number of fascinating research questions about the role of genes, hormones, and life events on the onset and course of MS. It also raises important clinical questions about how best to provide whole-person care for women and men living with MS.

Investigating how hormone therapies might affect MS

We are collaborating with Drs. Jonah Chan and Ari Green to determine the effects of a hormonal treatment on myelin repair, both in the laboratory, and in women with MS

Learn more here.

We just completed the first trial testing a hormonal therapy in menopausal women with MS, with support from the NMSS

Managing MS across the reproductive lifespan



After leading some of the initial observational studies suggesting that MS worsening may accelerate with reproductive aging, we are now focused on improving the quality of life of women during the menopausal transition. Find out more here.

Gender in the clinic

Initiative for gender-based care in the clinic: Including childbearing, hormone use, menopause, men's health concerns, as well as the unique concerns of sexual and gender minorities, including trans persons using gender affirming therapies.

Experiences of sexual and gender minority people living with multiple sclerosis in Northern California: An exploratory study

Find out more here.


Focus on evolutionary aspects of MS, including how hormonal exposures may interact with genes that regulate immune function and risk for MS.